DTx Pharma accepted into CONNECT Springboard Accelerator Program

//DTx Pharma accepted into CONNECT Springboard Accelerator Program

DTx Pharma accepted into CONNECT Springboard Accelerator Program

DTx Pharma, a RNA-based therapeutics company, announced that it has been accepted into the prestigious CONNECT mentoring program.  CONNECT is a program whose graduates have gone onto raise over $1.5 billion dollars in capital and whose companies have created over 4000 jobs.  DTx entered expects to graduate in Q2, 2017.  Further details on the CONNECT Springboard Accelerator Program are available at http://connect.catalyst-inc.org/springboard-accelerator.

By | 2018-02-28T00:41:47+00:00 December 1st, 2017|Uncategorized|0 Comments